Solid-Phase Synthesis of the Bicyclic Peptide OL-CTOP Containing Two Disulfide Bridges, and an Assessment of Its In Vivo μ-Opioid Receptor Antagonism after Nasal Administration.
Solid-Phase Synthesis of the Bicyclic Peptide OL-CTOP Containing Two Disulfide Bridges, and an Assessment of Its In Vivo μ-Opioid Receptor Antagonism after Nasal Administration.
复制标题
DOI:
10.3390/molecules28041822
复制
发表时间:
2023-02-15
期刊:
影响因子:
4.6
通讯作者:
Cudic, Predrag
中科院分区:
文献类型:
--
作者:
Rayala, Ramanjaneyulu;Tiller, Annika;Majumder, Shahayra A. A.;Stacy, Heather M. M.;Eans, Shainnel O. O.;Nedovic, Aleksandra;McLaughlin, Jay P. P.;Cudic, Predrag
关键词:
New strategies facilitate the design of cyclic peptides which can penetrate the brain. We have designed a bicyclic peptide, OL-CTOP, composed of the sequences of a selective μ-opioid receptor antagonist, CTOP (f-cyclo(CYwOTX)T) (X = penicillamine, Pen; O = ornithine) and odorranalectin, OL (YASPK-cyclo(CFRYPNGVLAC)T), optimized its solid-phase synthesis and demonstrated its ability for nose-to-brain delivery and in vivo activity. The differences in reactivity of Cys and Pen thiol groups protected with trityl and/or acetamidomethyl protecting groups toward I2 in different solvents were exploited for selective disulfide bond formation on the solid phase. Both the single step and the sequential strategy applied to macrocyclization reactions generated the desired OL-CTOP, with the sequential strategy yielding a large quantity and better purity of crude OL-CTOP. Importantly, intranasally (i.n.s.) administered OL-CTOP dose-dependently antagonized the analgesic effect of morphine administered to mice through the intracerebroventricular route and prevented morphine-induced respiratory depression. In summary, the results demonstrate the feasibility of our solid-phase synthetic strategy for the preparation of the OL-CTOP bicyclic peptide containing two disulfide bonds and reveal the potential of odorranalectin for further modifications and the targeted delivery to the brain.
登录
查看更多内容
影响因子:
5
作者:
GULYA, K;KRIVAN, M;KOVACS, GL
通讯作者:
KOVACS, GL
影响因子:
2.4
作者:
Hanson LR;Frey WH 2nd
通讯作者:
Frey WH 2nd
影响因子:
5
作者:
DEVINE, DP;LEONE, P;WISE, RA
通讯作者:
WISE, RA
DOI:
10.5059/yukigoseikyokaishi.75.1171
发表时间:
2017-11-01
影响因子:
0.2
作者:
Cary, Douglas R.;Ohuchi, Masaki;Masuya, Keiichi
通讯作者:
Masuya, Keiichi
影响因子:
8.8
作者:
Al-Hasani R;Bruchas MR
通讯作者:
Bruchas MR